Recommended Pages at oncologyreport.com
Breast Cancer More Lethal in Men : IMNG Oncology Report
oncologyreport.com — “The Oncology Report is an independent news source that provides oncologists with timely and relevant news and commentary about clinical developments in the field and about the impact of health care policy on the specialty and the physician's practice. The Oncology Report is owned by the International Medical News Group (IMNG) division of Elsevier.” View full resource at oncologyreport.com
Most Recently Shared on May 4, 2012 at 8:29 pm By:
Bob Finn - Medical News Net Health News
Men with breast cancer died more than 2 years sooner than women - http://t.co/dQte9FCa
Duodenal GIST Responds to Surgery, Imatinib : IMNG Oncology Report
oncologyreport.com — “The Oncology Report is an independent news source that provides oncologists with timely and relevant news and commentary about clinical developments in the field and about the impact of health care policy on the specialty and the physician's practice. The Oncology Report is owned by the International Medical News Group (IMNG) division of Elsevier.” View full resource at oncologyreport.com
Most Recently Shared on May 3, 2012 at 4:30 pm By:
Bob Finn - Medical News Net Health News
Surgery and imatinib yield good overall survival for duodenal GIST. http://t.co/bnpryaMs
It's March Madness! : IMNG Oncology Report
oncologyreport.com — “The Oncology Report is an independent news source that provides oncologists with timely and relevant news and commentary about clinical developments in the field and about the impact of health care policy on the specialty and the physician's practice. The Oncology Report is owned by the International Medical News Group (IMNG) division of Elsevier.” View full resource at oncologyreport.com
Most Recently Shared on March 23, 2012 at 3:45 pm By:
Bob Finn - Medical News Net Health News
March Madness will begin again next week as the Supreme Court hears oral arguments on the Affordable Care Act - http://t.co/pETyhwom
Ten Biomarkers May Aid Lung Cancer Detection : IMNG Oncology Report
oncologyreport.com — “The Oncology Report is an independent news source that provides oncologists with timely and relevant news and commentary about clinical developments in the field and about the impact of health care policy on the specialty and the physician's practice. The Oncology Report is owned by the International Medical News Group (IMNG) division of Elsevier.” View full resource at oncologyreport.com
Most Recently Shared on March 22, 2012 at 3:18 pm By:
Bob Finn - Medical News Net Health News
Ten biomarkers could aid in the detection of lung cancer - http://t.co/AuxyetJ2
Study: Myeloma Survival Gains, but QOL Slides : IMNG Oncology Report
oncologyreport.com — “The Oncology Report is an independent news source that provides oncologists with timely and relevant news and commentary about clinical developments in the field and about the impact of health care policy on the specialty and the physician's practice. The Oncology Report is owned by the International Medical News Group (IMNG) division of Elsevier.” View full resource at oncologyreport.com
Most Recently Shared on March 19, 2012 at 6:39 pm By:
Bob Finn - Medical News Net Health News
Patients with multiple myeloma can live longer, but their quality of life suffers, study says. http://t.co/50XpzIEw
More Extensive Gene Profiling Urged in AML, MDS : IMNG Oncology Report
oncologyreport.com — “The Oncology Report is an independent news source that provides oncologists with timely and relevant news and commentary about clinical developments in the field and about the impact of health care policy on the specialty and the physician's practice. The Oncology Report is owned by the International Medical News Group (IMNG) division of Elsevier.” View full resource at oncologyreport.com
Most Recently Shared on March 14, 2012 at 9:13 pm By:
Bob Finn - Medical News Net Health News
Two studies show the value of genetic profiling for acute myeloid leukemia and myelodysplastic syndrome - http://t.co/vViPVjUT
Exposure to Diesel Exhaust Tied to More Lung Cancer Deaths : IMNG Oncology Report
oncologyreport.com — “The Oncology Report is an independent news source that provides oncologists with timely and relevant news and commentary about clinical developments in the field and about the impact of health care policy on the specialty and the physician's practice. The Oncology Report is owned by the International Medical News Group (IMNG) division of Elsevier.” View full resource at oncologyreport.com
Most Recently Shared on March 13, 2012 at 7:27 pm By:
Bob Finn - Medical News Net Health News
The risk of developing, and dying from, lung cancer is increased by exposure to diesel exhaust - http://t.co/dtuk4OOX
Cisplatin Aids Survival of High-Risk Head and Neck Cancer : IMNG Oncology Report
oncologyreport.com — “The Oncology Report is an independent news source that provides oncologists with timely and relevant news and commentary about clinical developments in the field and about the impact of health care policy on the specialty and the physician's practice. The Oncology Report is owned by the International Medical News Group (IMNG) division of Elsevier.” View full resource at oncologyreport.com
Most Recently Shared on February 3, 2012 at 4:33 pm By:
Bob Finn - Medical News Net Health News
Adding chemotherapy to radiotherapy improved the survival rate of certain patients with head and neck cancer - http://t.co/cu3YHM3N
Gene Signature Predicts Response to Esophagogastric Cancer Therapy : IMNG Oncology Report
oncologyreport.com — “The Oncology Report is an independent news source that provides oncologists with timely and relevant news and commentary about clinical developments in the field and about the impact of health care policy on the specialty and the physician's practice. The Oncology Report is owned by the International Medical News Group (IMNG) division of Elsevier.” View full resource at oncologyreport.com
Most Recently Shared on February 2, 2012 at 8:18 pm By:
Bob Finn - Medical News Net Health News
A new 86-gene signature predicts response to esophagogastric cancer therapy. http://t.co/NmNclID1
FDA Adds Longer GIST Therapy to Imatinib Label : IMNG Oncology Report
oncologyreport.com — “The Oncology Report is an independent news source that provides oncologists with timely and relevant news and commentary about clinical developments in the field and about the impact of health care policy on the specialty and the physician's practice. The Oncology Report is owned by the International Medical News Group (IMNG) division of Elsevier.” View full resource at oncologyreport.com
Most Recently Shared on February 1, 2012 at 8:51 pm By:
Bob Finn - Medical News Net Health News
FDA adds a longer GIST therapy period to label for imatinib - http://t.co/tLjRCKdb
Glucarpidase Approved to Treat Methotrexate Toxicity : IMNG Oncology Report
oncologyreport.com — “The Oncology Report is an independent news source that provides oncologists with timely and relevant news and commentary about clinical developments in the field and about the impact of health care policy on the specialty and the physician's practice. The Oncology Report is owned by the International Medical News Group (IMNG) division of Elsevier.” View full resource at oncologyreport.com
Most Recently Shared on January 18, 2012 at 5:42 pm By:
Bob Finn - Medical News Net Health News
Glucarpidase was approved by the FDA for treating patients with toxic levels of methotrexate in their blood - http://t.co/8ntYSODP
Pediatric Hodgkin's Regimens Suit Adolescents and Young Adults : IMNG Oncology Report
oncologyreport.com — “The Oncology Report is an independent news source that provides oncologists with timely and relevant news and commentary about clinical developments in the field and about the impact of health care policy on the specialty and the physician's practice. The Oncology Report is owned by the International Medical News Group (IMNG) division of Elsevier.” View full resource at oncologyreport.com
Most Recently Shared on December 21, 2011 at 7:44 pm By:
Bob Finn - Medical News Net Health News
Pediatric Hodgkin's lymphoma regimens suit adolescents and young adults http://t.co/GDV6WZO1
T-DM1 Supports QOL in HER2+ Metastatic Breast Cancer : IMNG Oncology Report
oncologyreport.com — “The Oncology Report is an independent news source that provides oncologists with timely and relevant news and commentary about clinical developments in the field and about the impact of health care policy on the specialty and the physician's practice. The Oncology Report is owned by the International Medical News Group (IMNG) division of Elsevier.” View full resource at oncologyreport.com
Most Recently Shared on December 21, 2011 at 4:53 pm By:
Bob Finn - Medical News Net Health News
T-DM1 supports quality of life in patients with HER2-positive metastatic breast cancer - http://t.co/PcnfgxdG
Metastatic Work-Up Not Needed for All N2/N3 Breast Cancers : IMNG Oncology Report
oncologyreport.com — “The Oncology Report is an independent news source that provides oncologists with timely and relevant news and commentary about clinical developments in the field and about the impact of health care policy on the specialty and the physician's practice. The Oncology Report is owned by the International Medical News Group (IMNG) division of Elsevier.” View full resource at oncologyreport.com
Most Recently Shared on December 21, 2011 at 4:17 pm By:
Bob Finn - Medical News Net Health News
Breast cancer patients with multiple nodal disease need a metastatic work-up only if they have tumor grade 3 or 4 - http://t.co/HfSCo8G1
Brachytherapy Doubles Breast Loss Risk : IMNG Oncology Report
oncologyreport.com — “The Oncology Report is an independent news source that provides oncologists with timely and relevant news and commentary about clinical developments in the field and about the impact of health care policy on the specialty and the physician's practice. The Oncology Report is owned by the International Medical News Group (IMNG) division of Elsevier.” View full resource at oncologyreport.com
Most Recently Shared on December 7, 2011 at 8:05 pm By:
Damian McNamara Health Communicator
RT @MedicalNewsNet: News out of the San Antonio B.C. Symposium: Brachytherapy appears to up risk of future breast loss::http://t.co/Hh3yyWJK
